Our oral cell therapy is made to target Crohn's Disease and to deploy the healing cells directly at the site of inflammation. Decades of experience have established that cell therapies are safe and have few, if any, side effects. Further, there is an unmet need in Crohn's since most current drugs, including biologics, fall short and come with many adverse effects.
Our second target indication is aging-frailty and aging-related neurological disorders. This clinical strategy has great potential, since there is a growing aging population and increasing awareness about the advantages of using stem cells in anti-aging products.